Y108 | ÇǶóÁ¹·ÐÀ¯µµÃ¼¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, ±âŸ ¸í½ÃµÈ Àå¼Ò | Poisoning by and exposure to pyrazolone derivatives, other specified places |
 |
Y109 | ºñ¸¶¾à¼º ÁøÅëÁ¦, ÇØ¿Á¦, Ç×·ù¸¶Æ¼½ºÁ¦¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, »ó¼¼ºÒ¸í Àå¼Ò | Poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics, undetermined intent, unspecified place |
 |
Y109 | ºñ½ºÅ×·ÎÀ̵åÇ׿°Á¦¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, »ó¼¼ºÒ¸í Àå¼Ò | Poisoning by and exposure to nonsteroidal anti-inflammatory drugs [NSAID], undetermined intent, unspecified place |
 |
Y109 | 4-¾Æ¹Ì³ëÆä³îÀ¯µµÃ¼¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, »ó¼¼ºÒ¸í Àå¼Ò | Poisoning by and exposure to 4-aminophenol derivatives, undetermined intent, unspecified place |
 |
Y109 | »ì¸®½Ã¸°»ê¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, »ó¼¼ºÒ¸í Àå¼Ò | Poisoning by and exposure to salicylates, unspecified place |
 |
Y109 | ÇǶóÁ¹·ÐÀ¯µµÃ¼¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, »ó¼¼ºÒ¸í Àå¼Ò | Poisoning by and exposure to pyrazolone derivatives, unspecified place |
 |
Y11 | ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Ç×°£ÁúÁ¦, ÁøÁ¤Á¦-ÃÖ¸éÁ¦, ÇׯÄŲ½¼Á¦ ¹× Á¤½ÅÀÛ¿ë¾à¹°¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, undetermined intent, NEC |
 |
Y11 | ¹ÙºñÃò·¹ÀÌÆ®¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to barbiturates, undetermined intent |
 |
Y11 | ¸ÞŸÄí¾Ë·Ð ÈÇÕ¹°¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to betaqualone compounds, undetermined intent |
 |
Y11 | ¼®½Ã´Ï¸¶À̵å¿Í ¿Á»çÁ¹¸®µò¿¡µð¿Â¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to succinimide and oxazolidinediones, undetermined intent |
 |
Y11 | ½Å°æÀÌ¿ÏÁ¦¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to neuroleptics, tranquillizers, undetermined intent |
 |
Y11 | À̹̳뽺ƿº¥¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure toiminostilbenes, undetermined intent |
 |
Y11 | Á¤½ÅÈïºÐÁ¦¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to psychostimulants, undetermined intent |
 |
Y11 | È÷´ÜÅäÀÎÀ¯µµÃ¼¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to hydantoin derivatives, undetermined intent |
 |
Y11 | Ç׿ì¿ïÁ¦¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ | Poisoning by and exposure to antidepressants, undetermined intent |
 |
Y110 | ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Ç×°£ÁúÁ¦, ÁøÁ¤Á¦-ÃÖ¸éÁ¦, ÇׯÄŲ½¼Á¦ ¹× Á¤½ÅÀÛ¿ë¾à¹°¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, ÁÖ°ÅÁö | Poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, undetermined intent, NEC, home |
 |
Y110 | ¹ÙºñÃò·¹ÀÌÆ®¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, ÁÖ°ÅÁö | Poisoning by and exposure to barbiturates, undetermined intent, home |
 |
Y110 | ¸ÞŸÄí¾Ë·Ð ÈÇÕ¹°¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, ÁÖ°ÅÁö | Poisoning by and exposure to betaqualone compounds, undetermined intent, home |
 |
Y110 | ¼®½Ã´Ï¸¶À̵å¿Í ¿Á»çÁ¹¸®µò¿¡µð¿Â¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, ÁÖ°ÅÁö | Poisoning by and exposure to succinimide and oxazolidinediones, undetermined intent, home |
 |
Y110 | ½Å°æÀÌ¿ÏÁ¦¿¡ ÀÇÇÑ Àǵµ ¹ÌÈ®ÀÎÀÇ Áßµ¶ ¹× ³ëÃâ, ÁÖ°ÅÁö | Poisoning by and exposure to neuroleptics, tranquillizers, undetermined intent, home |
 |